FormsNet3 - Blank Form


 

 
Sequence Number:    

 

 
Date Received: __ __ __ __ - __ __- __ __  

 

 
CIBMTR Center Number:    

 

 
CIBMTR Recipient ID:    

 

 
Date of HCT for which this form is being completed: __ __ __ __ - __ __- __ __  

HCT Type: (check all that apply)  

 

 

gfedcb
Autologous

 

 

gfedcb
Allogeneic, unrelated

 

 

gfedcb
Allogeneic, related

Product type: (check all that apply)  

 

 

gfedcb
Bone marrow

 

 

gfedcb
PBSC

 

 

gfedcb
Single cord blood unit

 

 

gfedcb
Multiple cord blood units

 

 

gfedcb
Other product

 

 
Specify:    

 

 
Visit

  
 nmlkji

100 day  
 nmlkji

6 months  
 nmlkji

1 year  
 nmlkji

2 years  
 nmlkji

> 2 years,  

 

 
Specify:    

 

 
1  Did the recipient have lymphoma at the time of HCT?

    
 nmlkji

yes  
 nmlkji

no  

 

 
2  Did the recipient develop lymphoma or have persistent disease since the date of last report?

    
 nmlkji

yes  
 nmlkji

no  

 

 
3  Specify current status of lymphoma

    
 nmlkji

Complete remission (CR)  -complete disappearance of all known disease for ≥ 4 weeks 

 nmlkji
Partial remission (PR)  - ≥50% reductions in greatest diameter of all sites of known disease and no new sites  

 nmlkji
Stable disease (SD)  - <50% reductions in greatest diameter of all sites of known disease  

 nmlkji
Progressive disease (PD)  - increase in size of known disease, or new sites of disease  

 nmlkji
Unknown  

 nmlkji
Not assessed  

 

 
4  Did colitis persist or develop since the date of the last report?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

  Key Fields 

  Disease Assessment Since the Date of Last Report Questions: 1 - 19

Form 2134 R3.0: X-Linked Lymphoproliferative Syndrome (XLP) Post-HCT Data  
Center:  CRID: 

           CIBMTR Form 2134 revision 3.0 last updated October 2013 
Copyright(c) 2012 National Marrow Donor Program and 

The Medical College of Wisconsin, Inc. All rights reserved. 

Page 1 / 4



 

 
5  What is the status of colitis?

    
 nmlkji

Active  
 nmlkji

Inactive  
 nmlkji

Unknown  

 

 
6  Was the recipient receiving therapy for colitis?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

 
7  Did vasculitis persist or develop since the date of the last report?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

Specify vasculitis involvement:  

 

 
8  Central nervous system

    
 nmlkji

yes  
 nmlkji

no  

 

 
9  What is the status of the CNS vasculitis?

    
 nmlkji

Active  
 nmlkji

Inactive  
 nmlkji

Unknown  

 

 
10  Was the recipient receiving therapy for CNS vasculitis?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

 
11  Pulmonary system

    
 nmlkji

yes  
 nmlkji

no  

 

 
12  What is the status of the pulmonary vasculitis?

    
 nmlkji

Active  
 nmlkji

Inactive  
 nmlkji

Unknown  

 

 
13  Was the recipient receiving therapy for pulmonary vasculitis?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

 
14  Other vasculitis involvement

    
 nmlkji

yes  
 nmlkji

no  

 

 
15  Specify other vasculitis involvement:    

 

 
16  What is the status of other vasculitis?

    
 nmlkji

Active  
 nmlkji

Inactive  
 nmlkji

Unknown  

 

 
17  Was the recipient receiving therapy for other vasculitis?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

 
18  Did the recipient have hemophagocytic lymphohistiocytosis (HLH) prior to transplant or did it present since the date of last report?

    
 nmlkji

yes  
 nmlkji

no  

 

 
19  Specify the status of the HLH disease since the date of the last report:

    
 nmlkji

Active  

 nmlkji
Inactive  (quiescent) 

 

 
20  Did the recipient receive supplemental intravenous immunoglobulins (IVIG)?

    
 nmlkji

yes  
 nmlkji

no  

  Current Assessment of Immunologic Function Post-HCT Questions: 20 - 30

Form 2134 R3.0: X-Linked Lymphoproliferative Syndrome (XLP) Post-HCT Data  
Center:  CRID: 

           CIBMTR Form 2134 revision 3.0 last updated October 2013 
Copyright(c) 2012 National Marrow Donor Program and 

The Medical College of Wisconsin, Inc. All rights reserved. 

Page 2 / 4



 

 
21  Was therapy ongoing within three months of immunoglobulin testing?

    
 nmlkji

yes  
 nmlkji

no  

 

 
22  IgG

    
 nmlkji

Known  
 nmlkji

Unknown  

 

 
23     

 

 

 nmlkji
mg/dL  

 nmlkji
g/dL  

 nmlkji
g/L  

 

 
24  IgM

    
 nmlkji

Known  
 nmlkji

Unknown  

 

 
25     

 

 

 nmlkji
mg/dL  

 nmlkji
g/dL  

 nmlkji
g/L  

 

 
26  IgA

    
 nmlkji

Known  
 nmlkji

Unknown  

 

 
27     

 

 

 nmlkji
mg/dL  

 nmlkji
g/dL  

 nmlkji
g/L  

 

 
28  IgE

    
 nmlkji

Known  
 nmlkji

Unknown  

 

 
29     IU/mL 

 

 
30  NK cell function

    
 nmlkji

Absent  (≤ 10% lower limit of normal) 

 nmlkji
Decreased  (11-50% lower limit of normal) 

 nmlkji
Normal  

 nmlkji
Unknown  

 

 
31  Serum ferritin

    
 nmlkji

Known  
 nmlkji

Unknown  

 

 
32     µg/L 

 

 
33  Soluble interleukin-2 receptor (sIL-2R)

    
 nmlkji

Known  
 nmlkji

Unknown  

 

 
34     

 

 

 nmlkji
mg/dL  

 nmlkji
µmol/L  

 nmlkji
U/mL  

 

 
35  Triglycerides

    
 nmlkji

Known  
 nmlkji

Unknown  

 

 
36     

 

 

 nmlkji
mg/dL  

 nmlkji
mmol/L  

 

 
37  Fibrinogen antigen assay (factor I; fibrinogen activity; functional fibrinogen; fibrinogen antigen)

    
 nmlkji

Known  
 nmlkji

Unknown  

 

 
38     

 

 

 nmlkji
g/dL  

 nmlkji
mg/dL  

 nmlkji
µmol/L  

 nmlkji
g/L  

  Laboratory Studies at the Time of Evaluation for This Reporting Period Questions: 31 - 41

Form 2134 R3.0: X-Linked Lymphoproliferative Syndrome (XLP) Post-HCT Data  
Center:  CRID: 

           CIBMTR Form 2134 revision 3.0 last updated October 2013 
Copyright(c) 2012 National Marrow Donor Program and 

The Medical College of Wisconsin, Inc. All rights reserved. 

Page 3 / 4



 

 
39  Bone marrow aspirate / biopsy evidence of hemophagocytosis

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Not done  

Specify the cerebrospinal fluid findings: 

 

 
40  Protein

    
 nmlkji

Normal  
 nmlkji

Elevated  
 nmlkji

Not done  

 

 
41  WBC count

    
 nmlkji

Normal  
 nmlkji

Elevated  
 nmlkji

Not done  

 

 
First Name:    

 

 
Last Name:    

 

 
E-mail address:    

 

 
Date: __ __ __ __ - __ __- __ __  

Form 2134 R3.0: X-Linked Lymphoproliferative Syndrome (XLP) Post-HCT Data  
Center:  CRID: 

           CIBMTR Form 2134 revision 3.0 last updated October 2013 
Copyright(c) 2012 National Marrow Donor Program and 

The Medical College of Wisconsin, Inc. All rights reserved. 

Page 4 / 4